Meher Pharma International
provides an array of pharmaceutical regulatoryconsultancy and outsourcing services which includes FDA approvals, NPPA settlement,Contract manufacturing outsourcing, Export dossiers preparation, Documentlegalization from various embassies including Legal & HR services.
We innovate FDCs as per the guideline of WHO followed by DCGI so there is nochances of getting ban in near future. We offer technology for manufacturing of finishedproduct and also assist in procurement of vendors for raw material validation. Our fewinnovated FDCs are as follows:
CEFIXIME + OFLOXACIN-PLAIN & SRPRASUGREL + ROSUVASTATINCEFIXIME + MOXIFLOXACINCEFPODOXIME 100/200/400-SRCEFIXIME 100/200/400-SRTAPENTADOL + PARACETAMOLNIACIN + POLYCOSANOL
We are assisting in approvals of drugs/bulk drugs/medical device/vaccine &cosmetics for manufacturing and marketing in India.We do documentation and submission of Application
To name a few services are Export NOC/Import NOC/ Import Registration/Form-29/Import Test License/Neutral code/BE export NOC
Meher assists in consultancy and liasoning to pharmaceutical manufacturers, importersand distributors for Pharma price regulatory affairs with the NPPA. Our services include:
Appeal against Overcharging order/penalty imposed by NPPA.
We assist in selecting WHO certified third party pharmaceutical manufacturers.Exporters will be informed in advance about the product range, manufacturingfacility, product quality, delivery time and payment terms of manufacturers.We undertake export dossier compilation and preparation includingregional/ACTD/CTD.We can provide you economical bioequivalence (B.E) study for export especiallyfor the purpose of product registration in various part of the world.We can provide fastest export NOC with negligible chances of deficiencyWe can provide B.E.export NOC with negligible chances of deficiency